Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q2 FY23 results · Jul–Sep 2022
Amrutanjan Health Care reported revenue from operations of ₹110.72 crore (up 0.3% from Q2 FY22) and net profit of ₹12.77 crore (down 35.7% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a standalone basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 110.72 | 110.38 | +0.3% | 70.95 | +56.0% |
| Other income | 3.03 | 4.29 | −29.2% | 3.01 | +0.7% |
| Total income | 113.75 | 114.67 | −0.8% | 73.97 | +53.8% |
| Profit before tax | 17.42 | 26.36 | −33.9% | 5.25 | +231.8% |
| Net profit for the period | 12.77 | 19.85 | −35.7% | 3.66 | +248.4% |
| EPS, basic (₹) | 4.37 | 6.79 | −35.6% | 1.25 | +249.6% |
| Net margin (%) | 11.5 | 18.0 | 5.2 |
Standalone
- Filed with BSE
- 17 Nov 2022, 17:45 IST
- Board meeting
- 04 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE